The ADWYA Company has just announced that its Board of Directors had met on February 27th and closed the financial statements for the year ended December 31, 2017, showing a net profit of around 4.9 million dinars, up 80% from 2016.
During the year 2017, the company has achieved a turnover of 95 million dinars against 84 million a year ago, recording an increase of 13%, reads the release.
This performance comes from the increase in sales of generic drugs by 18% compared to 2016.
The company also points out that it achieved a gross operating income of 10.2 million dinars, posting an increase of 61% over the previous year, and a pre-tax profit of 6.5 million dinars, up 81.5%.
The Board has therefore decided to convene an Ordinary General Meeting on Friday, May 25, 2018 and to propose the distribution of a dividend of 0.140 dinar per share for the 2017 financial year against a dividend of 0.240 dinar for 2016.
In addition, the company will hold the same day an Extraordinary General Meeting to deliberate on a capital increase of 936 thousand dinars by incorporation of reserves.
